Results 111 to 120 of about 142,371 (238)

Allergic conjunctivitis.

open access: yesAsian Pacific journal of allergy and immunology, 2002
The purpose of this research is to study the clinical features and risk factors of various types of allergic conjunctivitis. Four hundred and forty-five patients with a history of itching, foreign body sensation, lacrimation and red eyes were examined, and a skin test was performed and assessed to grade the severity. The mean age of the subjects was 24.
P, Kosrirukvongs   +3 more
openaire   +1 more source

A Randomized Phase II Study of Subcutaneous Mosunetuzumab in Combination With Polatuzumab Vedotin Compared With Rituximab Plus Polatuzumab Vedotin in Patients With Relapsed or Refractory Large B‐Cell Lymphoma

open access: yesAmerican Journal of Hematology, Volume 101, Issue 9, Page 2177-2189, September 2026.
ABSTRACT Mosunetuzumab plus polatuzumab vedotin has shown promising activity versus rituximab plus polatuzumab vedotin (R‐Pola) in patients with relapsed/refractory (R/R) large B‐cell lymphoma (LBCL; NCT03671018). We present results from the Phase II randomized cohort, evaluating subcutaneous mosunetuzumab plus polatuzumab vedotin (Mosun‐Pola), with ...
Julio C. Chavez   +17 more
wiley   +1 more source

Viral Conjunctivitis Rates Unchanged Before and During the COVID-19 Pandemic in an Ophthalmology Clinic

open access: yesClinical Ophthalmology
Amber N Piazza,1 Peter A Downie,1,2 Michael S Lee,3 Bruce R Lindgren,4 Joshua H Olson3 1Medical School, University of Minnesota, Minneapolis, MN, 55455, USA; 2Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, WI ...
Piazza AN   +4 more
doaj  

Carbamazepine‐Induced Stevens‐Johnson Syndrome/Toxic Epidermal Necrolysis Overlap With Severe Ocular and Oral Involvement: A Pediatric Case Report From Uganda

open access: yesClinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT We report a case of carbamazepine‐induced Stevens‐Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) overlap in an 11‐year‐old Ugandan boy who presented with fever, facial swelling, ocular redness with photophobia, painful oral ulceration, and widespread epidermal detachment involving more than 10% of the body surface area.
Abdisalam Ahmed Sandeyl   +5 more
wiley   +1 more source

Comparing the Efficacy of Topical Anti- Allergic Preparations in the Treatment of Allergic Conjunctivitis

open access: yes, 2014
Objectives: This research study compared the efficacy of three anti-allergic preparations commonly used in the treatment of allergic conjunctivitis.Materials and Method: A randomized, double-masked, placebo-controlled multicenter study was conducted for ...
George, G O, Odjimogho, S E
core   +1 more source

Phenotypic Clusters of Severe Asthma and Response to Dupilumab in Real‐World Practice

open access: yesClinical and Translational Allergy, Volume 16, Issue 9, September 2026.
ABSTRACT Background Severe asthma is a heterogeneous disease with variable clinical and inflammatory profiles that may influence responses to biological therapies. Identifying phenotypic clusters may help optimize patient selection and treatment outcomes.
Daria S. Fomina   +9 more
wiley   +1 more source

Long-term effects of air pollution on daily outpatient visits for allergic conjunctivitis from 2013 to 2020: a time-series study in Urumqi, China

open access: yesFrontiers in Public Health
IntroductionThis study aimed to elucidate the effects of outdoor air pollution and allergic conjunctivitis and population-based lagged effects of air pollution.MethodsWe included data on six major air pollutants, PM10, PM2.5, carbon monoxide (CO), sulfur
Dongwei Liu   +8 more
doaj   +1 more source

Real‐World Efficacy and Systemic Immune Modulation Upon Tralokinumab Treatment in Atopic Dermatitis

open access: yesClinical and Translational Allergy, Volume 16, Issue 9, September 2026.
ABSTRACT Background Tralokinumab, an interleukin‐13 (IL‐13) monoclonal antibody, has shown clinical efficacy in randomized trials for moderate‐to‐severe atopic dermatitis (AD). This study aims to evaluate clinical and immunological outcome upon tralokinumab treatment in a real‐world cohort of patients with moderate‐to‐severe AD. Methods We recruited 81
Meslina Almaci   +3 more
wiley   +1 more source

Updates in the treatment of ocular allergies

open access: yesJournal of Asthma and Allergy, 2010
Osmo Kari1, K Matti Saari21Department of Allergology, Skin and Allergy Hospital, Helsinki University Central Hospital, Helsinki, Finland; 2Department of Ophthalmology, University of Turku, Turku, FinlandAbstract: Allergic diseases have greatly increased ...
Osmo Kari, K Matti Saari
doaj  

Home - About - Disclaimer - Privacy